Technical Analysis for CSL - CSL Limited  

Grade Last Price % Change Price Change
C 287.920 0.55% 1.570
CSL closed up 0.55 percent on Thursday, March 28, 2024, on 89 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 50 DMA Bullish 0.55%
Bollinger Band Squeeze Range Contraction 0.55%
Stochastic Reached Overbought Strength 0.55%
BB Squeeze + Upper Band Touch Range Contraction 0.55%

   Recent Intraday Alerts

Alert Time
Up 1% about 16 hours ago
Rose Above Previous Day's High about 18 hours ago
Up 1 ATR 1 day ago
Possible NR7 1 day ago
Rose Above 50 DMA 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CSL Limited   Description

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Biotechnology Intellectual Property Biopharmaceutical Therapeutic Product Therapeutic Products Pharmaceutical Products In Vitro Pharmacology Diagnostic Products

Is CSL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 308.8426
52 Week Low 227.2563
Average Volume 712,048
200-Day Moving Average 267.934
50-Day Moving Average 285.960
20-Day Moving Average 281.267
10-Day Moving Average 281.548
Average True Range 3.980
RSI (14) 59.02
ADX 13.48
+DI 30.018
-DI 16.540
Chandelier Exit (Long, 3 ATRs) 277.821
Chandelier Exit (Short, 3 ATRs) 286.939
Upper Bollinger Bands 286.574
Lower Bollinger Band 275.961
Percent B (%b) 1.13
BandWidth 3.773
MACD Line 0.005
MACD Signal Line -1.018
MACD Histogram 1.0229
Fundamentals Value
Market Cap 131 Billion
Num Shares 455 Million
EPS 4.62
Price-to-Earnings (P/E) Ratio 62.39
Price-to-Sales 10.41
Price-to-Book 14.49
PEG Ratio 0.00
Dividend 2.94
Dividend Yield 1.02%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 292.090
Resistance 3 (R3) 292.240 291.000 291.395
Resistance 2 (R2) 291.000 289.938 290.925 291.163
Resistance 1 (R1) 289.460 289.282 288.840 289.310 290.932
Pivot Point 288.220 288.220 287.910 288.145 288.220
Support 1 (S1) 286.680 287.158 286.060 286.530 284.908
Support 2 (S2) 285.440 286.502 285.365 284.677
Support 3 (S3) 283.900 285.440 284.445
Support 4 (S4) 283.750